Javier Padillo-Ruiz-rekin lankidetzan egindako argitalpenak (3)

2016

  1. Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src [Oncotarget, 7, 22, (33111-33124) (2016)] DOI: 10.18632/oncotarget.8880

    Oncotarget

  2. Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

    Oncotarget, Vol. 7, Núm. 22, pp. 33111-33124

2013

  1. Targeting tyrosine kinase receptors in hepatocellular carcinoma

    Current Cancer Drug Targets, Vol. 13, Núm. 3, pp. 300-312